Source: International Congress 2017 – COPD management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Vargas-Castanho (LISBOA, Portugal). The importance of eosinophilic inflammation in COPD exacerbations. 1064

Member's Comments

No comment yet.

Related content which might interest you: Eosinophilic airway inflammation in COPD and asthma Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial Source: Eur Respir J 2007; 29: 906-913 Year: 2007 Acceleration of neutrophilic inflammation during COPD exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 505s Year: 2002 Change in inflammation during COPD exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 15s Year: 2005 Changes in bronchial inflammation during acute exacerbations of chronic bronchitis Source: Eur Respir J 2001; 17: 1112-1119 Year: 2001 Viral and bacterial etiology of severe COPD exacerbations: relationship with airway inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 251s Year: 2005 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Resolution of bronchial inflammation during exacerbations of chronic bronchitis relate to changes in bacteriology. Source: Eur Respir J 2002; 20: Suppl. 38, 592s Year: 2002 Asthma exacerbations and eosinophilic inflammation 6 months after treatment with mepolizumab in refractory eosinophilic asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 The pathological feature of airway inflammation in eosinophilic bronchitis Source: Eur Respir J 2005; 26: Suppl. 49, 282s Year: 2005 Eicosanoids and eosinophilic inflammation of airways in stable COPD. Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 The value of inflammation markers in acute infective exacerbations of bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 217s Year: 2001 Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction Source: Eur Respir J 2002; 20: Suppl. 38, 505s Year: 2002 The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Same role and same treatment for airway eosinophilia in asthma and COPD? Source: Eur Respir J 2007; 29: 831-833 Year: 2007 Role of colonization on inflammation in COPD patients with bronchiectasis Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008